MG-132 could increase TRAIL-induced apoptosis in both Bax-deficient and proficient colon cancer cells, which is suggestive of a sensitization mechanism independent of the mitochondrial pathway of apoptosis [24]. This evidence concerns the gene BAX and colonic neoplasm.